Sankaranarayanan Murugesan

According to our database, Sankaranarayanan Murugesan authored at least 3 papers between 2022 and 2025.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of five.

2025

Pharmacoinformatics-based prediction of Checkpoint kinase-1 inhibitors from Momordica charantia Linn. for cancer.

Subramanian Haripriya, Muniyandi Vijayalakshmi, Chandu Ala, Sankaranarayanan Murugesan, Parasuraman Pavadai, Selvaraj Kunjiappan, Sureshbabu Ram Kumar Pandian

Comput. Biol. Chem., 2025

2022

CoviRx: A User-Friendly Interface for Systematic Down-Selection of Repurposed Drug Candidates for COVID-19.

Hardik A. Jain, Vinti Agarwal, Chaarvi Bansal, Anupama Kumar, Faheem Faheem, Muzaffar-Ur-Rehman Mohammed, Sankaranarayanan Murugesan, Moana M. Simpson, Avinash V. Karpe, Rohitash Chandra, Christopher A. MacRaild, Ian K. Styles, Amanda L. Peterson, Matthew A. Cooper, Carl M. J. Kirkpatrick, Rohan M. Shah, Enzo A. Palombo, Natalie L. Trevaskis, Darren J. Creek, Seshadri S. Vasan

Data, 2022

<i>In silico</i> and <i>in vitro</i> analysis of PPAR - α / γ dual agonists: Comparative evaluation of potential phytochemicals with anti-obesity drug orlistat.

Sumit Kumar Mandal, Banoth Karan Kumar, Pankaj Kumar Sharma, Sankaranarayanan Murugesan, P. R. Deepa

Comput. Biol. Medicine, 2022